Pomegranate extracts and cancer prevention: Molecular and cellular activities

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 8, 2013, Pages 1149-1161

  Syed, Deeba N ^a   Chamcheu, Jean Christopher ^a   Adhami, Vaqar M ^a   Mukhtar, Hasan ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cancer prevention; Pomegranate extracts

Indexed keywords

ANTHOCYANIN; ASCORBIC ACID; COUMARIC ACID; ELLAGIC ACID; ELLAGITANNIN; FLAVONOID; FLAVONOL DERIVATIVE; HYDROXYBENZOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; POLYPHENOL; POMEGRANATE EXTRACT; PROTEIN KINASE B; RETINOL; TANNIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER PREVENTION; CELLULAR PARAMETERS; CHEMICAL CARCINOGENESIS; CHEMICAL COMPOSITION; COLON CANCER; COLON CARCINOGENESIS; DRUG BIOAVAILABILITY; DRUG MEGADOSE; HUMAN; LEUKEMIA; LOW DRUG DOSE; LUNG CANCER; MOLECULAR DYNAMICS; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); POMEGRANATE JUICE; PROSTATE CANCER; RADIATION CARCINOGENESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN CANCER; WOUND HEALING;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CARCINOGENESIS; CELL CULTURE TECHNIQUES; FLAVONOIDS; FRUIT; HUMANS; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; PUNICACEAE; WOUND HEALING;

EID: 84888248503     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520611313080003     Document Type: Article

References (84)

1. Mukhtar, H., Ahmad, N. Cancer chemoprevention: future holds inmultiple agents. Toxicol. Appl. Pharmacol., 1999, 158 (3), 207-10.
2. Syed, D. N., Afaq, F., Mukhtar, H. Pomegranate derived productsfor cancer chemoprevention. Semin. Cancer Biol., 2007, 17 (5), 377-85.
3. de Kok, T. M., de Waard, P., Wilms, L. C., van Breda, S. G. Antioxidative and antigenotoxic properties of vegetables and dietary phytochemicals: the value of genomics biomarkers in molecular epidemiology. Mol. Nutr. Food Res., 2010, 54 (2), 208-17.
4. Schwartz, E., Tzulker, R., Glazer, I., Bar-Ya'Akov, I., Wiesman, Z., Tripler, E., Bar-Ilan, I., Fromm, H., Borochov-Neori, H., Holland, D., Amir, R. Environmental conditions affect the color, taste, and antioxidant capacity of 11 pomegranate accessions' fruits. J. Agr. Food Chem., 2009, 57 (19), 9197-209.
5. Aviram, M., Kaplan, M., Rosenblat, M., Fuhrman, B. Dietaryantioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handbook of Exp. Pharmacol., 2005, (170), 263-300.
6. Kaufman, M., Wiesman, Z. Pomegranate oil analysis withemphasis on MALDI-TOF/MS triacylglycerol fingerprinting. J. Agr. Food Chem., 2007, 55 (25), 10405-13.
7. Gil, M. I., Tomas-Barberan, F. A., Hess-Pierce, B., Holcroft, D. M., Kader, A. A. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agr. Food Chem., 2000, 48 (10), 4581-9.
8. Guo, S., Deng, Q., Xiao, J., Xie, B., Sun, Z. Evaluation ofantioxidant activity and preventing DNA damage effect of pomegranate extracts by chemiluminescence method. J. Agr. Food Chem., 2007, 55 (8), 3134-40.
9. Rababah, T. M., Banat, F., Rababah, A., Ereifej, K., Yang, W. Optimization of extraction conditions of total phenolics, antioxidant activities, and anthocyanin of oregano, thyme, terebinth, and pomegranate. J. Food Sci., 2010, 75 (7), C626-32.
10. Qu, W., Breksa Iii, A. P., Pan, Z., Ma, H., McHugh, T. H. Storagestability of sterilized liquid extracts from pomegranate peel. J. Food Sci., 2012, 77 (7), C765-72.
11. Mirdehghan, S. H., Rahemi, M., Serrano, M., Guillen, F., Martinez-Romero, D., Valero, D. The application of polyamines by pressure or immersion as a tool to maintain functional properties in stored pomegranate arils. J. Agr. Food Chem., 2007, 55 (3), 755-60.
12. Fischer, U. A., Jaksch, A. V., Carle, R., Kammerer, D. R. Determination of lignans in edible and nonedible parts of pomegranate (Punica granatum L.) and products derived therefrom, particularly focusing on the quantitation of isolariciresinol using HPLC-DAD-ESI/MSn. J. Agr. Food Chem., 2012, 60 (1), 283-92.
13. Malik, A., Afaq, F., Sarfaraz, S., Adhami, V. M., Syed, D. N., Mukhtar, H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci U S A, 2005, 102 (41), 14813-8.
14. Khan, N., Afaq, F., Kweon, M. H., Kim, K., Mukhtar, H. Oralconsumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res., 2007, 67(7), 3475-82.
15. Perez-Vicente, A., Gil-Izquierdo, A., Garcia-Viguera, C. In vitrogastrointestinal digestion study of pomegranate juice phenolic compounds, anthocyanins, and vitamin C. J. Agr. Food Chem., 2002, 50 (8), 2308-12.
16. Cerda, B., Llorach, R., Ceron, J. J., Espin, J. C., Tomas-Barberan, F. A. Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eu. J. Nutr., 2003, 42 (1), 18-28.
17. Cerda, B., Espin, J. C., Parra, S., Martinez, P., Tomas-Barberan, F. A. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eu. J. Nutr., 2004, 43 (4), 205-20.
18. Cerda, B., Tomas-Barberan, F. A., Espin, J. C. Metabolism ofantioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability. J. Agr. Food Chem., 2005, 53 (2), 227-35.
19. Espin, J. C., Gonzalez-Barrio, R., Cerda, B., Lopez-Bote, C., Rey, A. I., Tomas-Barberan, F. A. Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. J. Agr. Food Chem., 2007, 55 (25), 10476-85.
20. Neyrinck, A. M., Van Hee, V. F., Bindels, L. B., De Backer, F., Cani, P. D., Delzenne, N. M. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota. Br. J. Nutr., 2012, 1-8.
21. Seeram, N. P., Lee, R., Heber, D. Bioavailability of ellagic acidin human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clinica Chimica Acta: Int. J. Clin. Chem., 2004, 348 (1-2), 63-8.
22. Mertens-Talcott, S. U., Jilma-Stohlawetz, P., Rios, J., Hingorani, L., Derendorf, H. Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J. Agr. Food Chem., 2006, 54 (23), 8956-61.
23. Seeram, N. P., Henning, S. M., Zhang, Y., Suchard, M., Li, Z., Heber, D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J. Nutr., 2006, 136 (10), 2481-5.
24. Bialonska, D., Kasimsetty, S. G., Khan, S. I., Ferreira, D. Urolithins, intestinal microbial metabolites of Pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay. J. Agr. Food Chem., 2009, 57 (21), 10181-6.
25. Seeram, N. P., Zhang, Y., McKeever, R., Henning, S. M., Lee, R. P., Suchard, M. A., Li, Z., Chen, S., Thames, G., Zerlin, A., Nguyen, M., Wang, D., Dreher, M., Heber, D. Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects. J. Med. Food, 2008, 11 (2), 390-4.
26. Lansky, E. P., Jiang, W., Mo, H., Bravo, L., Froom, P., Yu, W., Harris, N. M., Neeman, I., Campbell, M. J. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest. New Drugs, 2005, 23 (1), 11-20.
27. Albrecht, M., Jiang, W., Kumi-Diaka, J., Lansky, E. P., Gommersall, L. M., Patel, A., Mansel, R. E., Neeman, I., Geldof, A. A., Campbell, M. J. Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J. Med. Food, 2004, 7 (3), 274-83.
28. Lansky, E. P., Harrison, G., Froom, P., Jiang, W. G. Pomegranate(Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Invest. new drugs, 2005, 23 (2), 121-2.
29. Hong, M. Y., Seeram, N. P., Heber, D. Pomegranate polyphenolsdown-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. J. Nutr. Biochem., 2008, 19 (12), 848-55.
30. Rettig, M. B., Heber, D., An, J., Seeram, N. P., Rao, J. Y., Liu, H., Klatte, T., Belldegrun, A., Moro, A., Henning, S. M., Mo, D., Aronson, W. J., Pantuck, A. Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism. Mol. Cancer Ther., 2008, 7(9), 2662-71.
31. Afaq, F., Saleem, M., Krueger, C. G., Reed, J. D., Mukhtar, H. Anthocyanin-and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int. J. Cancer. J. Int. Du Cancer, 2005, 113 (3), 423-33.
32. Seeram, N. P., Aronson, W. J., Zhang, Y., Henning, S. M., Moro, A., Lee, R. P., Sartippour, M., Harris, D. M., Rettig, M., Suchard, M. A., Pantuck, A. J., Belldegrun, A., Heber, D. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J. Agr. Food Chem., 2007, 55 (19), 7732-7.
33. Adhami, V. M., Siddiqui, I. A., Syed, D. N., Lall, R. K., Mukhtar, H. Oral infusion of pomegranate fruit extract inhibits prostate carcinogenesis in the TRAMP model. Carcinogenesis, 2012, 33(3), 644-51.
34. Koyama, S., Cobb, L. J., Mehta, H. H., Seeram, N. P., Heber, D., Pantuck, A. J., Cohen, P. Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis. Growth Hormone & IGF Res., 2010, 20 (1), 55-62.
35. Seeram, N. P., Adams, L. S., Henning, S. M., Niu, Y., Zhang, Y., Nair, M. G., Heber, D. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J. Nutr. Biochem., 2005, 16 (6), 360-7.
36. Wang, L., Alcon, A., Yuan, H., Ho, J., Li, Q. J., Martins-Green, M. Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells. Integr. Biol., 2011, 3(7), 742-54.
37. Pantuck, A. J., Leppert, J. T., Zomorodian, N., Aronson, W., Hong, J., Barnard, R. J., Seeram, N., Liker, H., Wang, H., Elashoff, R., Heber, D., Aviram, M., Ignarro, L., Belldegrun, A. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin. Cancer Res., 2006, 12 (13), 4018-26.
38. Paller, C. J., Ye, X., Wozniak, P. J., Gillespie, B. K., Sieber, P. R., Greengold, R. H., Stockton, B. R., Hertzman, B. L., Efros, M. D., Roper, R. P., Liker, H. R., Carducci, M. A., A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. Prostate Cancer And Prostatic Diseases 2012.
39. Gonzalez-Sarrias, A., Gimenez-Bastida, J. A., Garcia-Conesa, M. T., Gomez-Sanchez, M. B., Garcia-Talavera, N. V., Gil-Izquierdo, A., Sanchez-Alvarez, C., Fontana-Compiano, L. O., Morga-Egea, J. P., Pastor-Quirante, F. A., Martinez-Diaz, F., Tomas-Barberan, F. A., Espin, J. C. Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice. Mol. Nutr. Food Res., 2010, 54(3), 311-22.
40. Kasimsetty, S. G., Bialonska, D., Reddy, M. K., Thornton, C., Willett, K. L., Ferreira, D. Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells. J. Agr. Food Chem., 2009, 57 (22), 10636-44.
41. Faria, A., Monteiro, R., Azevedo, I., Calhau, C. Pomegranate juiceeffects on cytochrome P450S expression: in vivo studies. J. Med. Food, 2007, 10 (4), 643-9.
42. Syed, D. N., Malik, A., Hadi, N., Sarfaraz, S., Afaq, F., Mukhtar, H. Photochemopreventive effect of pomegranate fruit extract on UVA-mediated activation of cellular pathways in normal human epidermal keratinocytes. Photochem. Photobiol., 2006, 82 (2), 398-405.
43. Afaq, F., Malik, A., Syed, D., Maes, D., Matsui, M. S., Mukhtar, H. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochem. Photobiol., 2005, 81 (1), 38-45.
44. Zaid, M. A., Afaq, F., Syed, D. N., Dreher, M., Mukhtar, H. Inhibition of UVB-mediated oxidative stress and markers of photoaging in immortalized HaCaT keratinocytes by pomegranate polyphenol extract POMx. Photochem. Photobiol., 2007, 83 (4), 882-8.
45. Pacheco-Palencia, L. A., Noratto, G., Hingorani, L., Talcott, S. T., Mertens-Talcott, S. U. Protective effects of standardized pomegranate (Punica granatum L.) polyphenolic extract in ultraviolet-irradiated human skin fibroblasts. J. Agr. Food Chem., 2008, 56 (18), 8434-41.
46. Afaq, F., Zaid, M. A., Khan, N., Dreher, M., Mukhtar, H. Protectiveeffect of pomegranate-derived products on UVB-mediated damage in human reconstituted skin. Exp. Dermatol., 2009, 18 (6), 553-61.
47. Afaq, F., Khan, N., Syed, D. N., Mukhtar, H. Oral feeding ofpomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Photochem. Photobiol., 2010, 86 (6), 1318-26.
48. Khan, N., Syed, D. N., Pal, H. C., Mukhtar, H., Afaq, F. Pomegranate Fruit Extract Inhibits UVB-induced Inflammation and Proliferation by Modulating NF-kappaB and MAPK Signaling Pathways in Mouse Skin(dagger). Photochem. Photobiol., 2011.
49. Rout, S., Banerjee, R. Free radical scavenging, anti-glycation andtyrosinase inhibition properties of a polysaccharide fraction isolated from the rind from Punica granatum. Bioresource Technol., 2007, 98 (16), 3159-63.
50. Yoshimura, M., Watanabe, Y., Kasai, K., Yamakoshi, J., Koga, T. Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and ultraviolet-induced pigmentation. Biosci. Biotechnol. Biochem., 2005, 69 (12), 2368-73.
51. Kasai, K., Yoshimura, M., Koga, T., Arii, M., Kawasaki, S. Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin. J. Nutr. Sci. Vitaminol., 2006, 52 (5), 383-8.
52. Hora, J. J., Maydew, E. R., Lansky, E. P., Dwivedi, C. Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice. J. Med. Food, 2003, 6 (3), 157-61.
53. George, J., Singh, M., Srivastava, A. K., Bhui, K., Shukla, Y. Synergistic growth inhibition of mouse skin tumors by pomegranate fruit extract and diallyl sulfide: evidence for inhibition of activated MAPKs/NF-kappaB and reduced cell proliferation. Food Chem. Toxicol., 2011, 49 (7), 1511-20.
54. Aslam, M. N., Lansky, E. P., Varani, J. Pomegranate as acosmeceutical source: pomegranate fractions promote proliferation and procollagen synthesis and inhibit matrix metalloproteinase-1 production in human skin cells. J. Ethnopharmacol., 2006, 103 (3), 311-8.
55. Murthy, K. N., Reddy, V. K., Veigas, J. M., Murthy, U. D. Study onwound healing activity of Punica granatum peel. J. Med. Food, 2004, 7 (2), 256-9.
56. Hayouni, E. A., Miled, K., Boubaker, S., Bellasfar, Z., Abedrabba, M., Iwaski, H., Oku, H., Matsui, T., Limam, F., Hamdi, M. Hydroalcoholic extract based-ointment from Punica granatum L. peels with enhanced in vivo healing potential on dermal wounds. Phytomedicine, 2011, 18 (11), 976-84.
57. Gimenez-Bastida, J. A., Larrosa, M., Gonzalez-Sarrias, A., Tomas-Barberan, F., Espin, J. C., Garcia-Conesa, M. T. Intestinal Ellagitannin Metabolites Ameliorate Cytokine-Induced Inflammationand Associated Molecular Markers in Human Colon Fibroblasts. J. Agr. Food Chem., 2012.
58. Gonzalez-Sarrias, A., Larrosa, M., Tomas-Barberan, F. A., Dolara, P., Espin, J. C. NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br. J. Nutr., 2010, 104 (4), 503-12.
59. Rosillo, M. A., Sanchez-Hidalgo, M., Cardeno, A., de la Lastra, C. A. Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease. Biochem. Pharmacol., 2011, 82 (7), 737-45.
60. Boussetta, T., Raad, H., Letteron, P., Gougerot-Pocidalo, M. A., Marie, J. C., Driss, F., El-Benna, J. Punicic acid a conjugated linolenic acid inhibits TNFalpha-induced neutrophil hyper-activation and protects from experimental colon inflammation in rats. PloS one, 2009, 4 (7), e6458.
61. Larrosa, M., Gonzalez-Sarrias, A., Yanez-Gascon, M. J., Selma, M. V., Azorin-Ortuno, M., Toti, S., Tomas-Barberan, F., Dolara, P., Espin, J. C. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J. Nutr. Biochem., 2010, 21 (8), 717-25.
62. Ogawa, Y., Kanatsu, K., Iino, T., Kato, S., Jeong, Y. I., Shibata, N., Takada, K., Takeuchi, K. Protection against dextran sulfate sodium-induced colitis by microspheres of ellagic acid in rats. Life Sci., 2002, 71 (7), 827-39.
63. Singh, K., Jaggi, A. S., Singh, N., Exploring the ameliorativepotential of Punica granatum in dextran sulfate sodium induced ulcerative colitis in mice. Phytotherapy Res., 2009, 23 (11), 1565-74.
64. Kasimsetty, S. G., Bialonska, D., Reddy, M. K., Ma, G., Khan, S. I., Ferreira, D., Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J. Agr. Food Chem., 2010, 58 (4), 2180-7.
65. Adams, L. S., Seeram, N. P., Aggarwal, B. B., Takada, Y., Sand, D., Heber, D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J. Agr. Food Chem., 2006, 54 (3), 980-5.
66. Larrosa, M., Tomas-Barberan, F. A., Espin, J. C. The dietaryhydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J. Nutr. Biochem., 2006, 17 (9), 611-25.
67. Sharma, M., Li, L., Celver, J., Killian, C., Kovoor, A., Seeram, N. P. Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling. J. Agr. Food Chem., 2010, 58 (7), 3965-9.
68. Kohno, H., Suzuki, R., Yasui, Y., Hosokawa, M., Miyashita, K., Tanaka, T. Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats. Cancer Sci., 2004, 95 (6), 481-6.
69. Cho, W. C., Kwan, C. K., Yau, S., So, P. P., Poon, P. C., Au, J. S. Therole of inflammation in the pathogenesis of lung cancer. Exp. Opin. Therap. Targets, 2011, 15 (9), 1127-37.
70. Bachoual, R., Talmoudi, W., Boussetta, T., Braut, F., El-Benna, J. An aqueous pomegranate peel extract inhibits neutrophil myeloperoxidase in vitro and attenuates lung inflammation in mice. Food Chem. Toxicol., 2011, 49 (6), 1224-8.
71. Khan, N., Hadi, N., Afaq, F., Syed, D. N., Kweon, M. H., Mukhtar, H. Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis 2007, 28 (1), 163-73.
72. Adams, L. S., Zhang, Y., Seeram, N. P., Heber, D., Chen, S. Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev. Res., 2010, 3 (1), 108-13.
73. Kim, N. D., Mehta, R., Yu, W., Neeman, I., Livney, T., Amichay, A., Poirier, D., Nicholls, P., Kirby, A., Jiang, W., Mansel, R., Ramachandran, C., Rabi, T., Kaplan, B., Lansky, E. Chemo-preventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res. Treatment, 2002, 71 (3), 203-17.
74. Grossmann, M. E., Mizuno, N. K., Schuster, T., Cleary, M. P. Punicic acid is an omega-5 fatty acid capable of inhibiting breast cancer proliferation. Int. J. Oncol., 2010, 36 (2), 421-6.
75. Tran, H. N., Bae, S. Y., Song, B. H., Lee, B. H., Bae, Y. S., Kim, Y. H., Lansky, E. P., Newman, R. A. Pomegranate (Punica granatum) seed linolenic acid isomers: concentration-dependent modulation of estrogen receptor activity. Endocrine Res., 2010, 35(1), 1-16.
76. Mehta, R., Lansky, E. P. Breast cancer chemopreventive propertiesof pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eu. J. Cancer Prev., 2004, 13 (4), 345-8.
77. Jeune, M. A., Kumi-Diaka, J., Brown, J. Anticancer activities ofpomegranate extracts and genistein in human breast cancer cells. J. Med. Food, 2005, 8 (4), 469-75.
78. Khan, G. N., Gorin, M. A., Rosenthal, D., Pan, Q., Bao, L. W., Wu, Z. F., Newman, R. A., Pawlus, A. D., Yang, P., Lansky, E. P., Merajver, S. D. Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integrat. Cancer Therapies, 2009, 8 (3), 242-53.
79. Toi, M., Bando, H., Ramachandran, C., Melnick, S. J., Imai, A., Fife, R. S., Carr, R. E., Oikawa, T., Lansky, E. P. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis, 2003, 6 (2), 121-8.
80. Joseph, M. M., Aravind, S. R., Varghese, S., Mini, S., Sreelekha, T. T. Evaluation of antioxidant, antitumor and immunomodulatory properties of polysaccharide isolated from fruit rind of Punica granatum. Mol. Med. Rep., 2012, 5 (2), 489-96.
81. Dahlawi, H., Jordan-Mahy, N., Clench, M. R., Le Maitre, C. L. Bioactive actions of pomegranate fruit extracts on leukemia cell lines in vitro hold promise for new therapeutic agents for leukemia. Nutr. Cancer, 2012, 64 (1), 100-10.
82. Li, Z., Percival, S. S., Bonard, S., Gu, L. Fabrication of nano particles using partially purified pomegranate ellagitannins and gelatin and their apoptotic effects. Mol. Nutr. Food Res., 2011, 55 (7), 1096-103.
83. Kawaii, S., Lansky, E. P. Differentiation-promoting activity ofpomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells. J. Med. Food, 2004, 7 (1), 13-8.
84. Ceesay, M. M., Vadher, B., Tinwell, B., Goderya, R., Sawicka, E. Spontaneous remission of T lymphoblastic lymphoma. J. Clin. Pathol., 2008, 61 (8), 955-7.